C-reactive protein (CRP) is an acute phase protein of hepatic origin in man whose plasma concentration increases markedly in response to a wide variety of inflammatory stimuli. CRP is a binding protein which, when bound to one of its ligands, has been found capable of activating complement, and affecting the function of phagocytic cells. CRP also contains tuftsin-like peptides and proteolytic fragments of CRP can stimulate inflammatory cells. These properties along with evolutionary conservation of the protein (which is even found in some invertebrates), have been interpreted as indicating that CRP functions to modulate the inflammatory response. The mouse, in contrast to most vertebrates, does not synthesize a significant quantity of CRP in response to inflammatory stimuli. We have taken advantage of this evolutionary oddity and produced transgenic mice capable of expressing rabbit CRP in order to define the functional role of CRP in vivo. These animals will be employed to assess the effects of rabbit CRP in three established mouse models of inflammation. We will: 1) Initially characterize the properties of CRP in our established transgenic mouse lines. 2) Determine the pathophysiologic and morphologic effects of transgenic CRP on endotoxic shock, antigen-induced acute arthritis and Lactobacillus induced carditis in these animals. 3) Test the in vivo importance of the phosphorylcholine (PC) binding domain of CRP since PC is a ubiquitous substrate to which CRP binds avidly. This domain will be altered by site directed mutagenesis of the rabbit CRP gene and, after confirmation that these mutants are unable to bind PC (following expression in transfected cell lines), will be employed to produce additional transgenic mice. The effects of altering the PC binding domain on the functional properties of CRP will be tested in the models outlined in 1) and 2) above.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040765-02
Application #
3161224
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1991-08-01
Project End
1995-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Jiang, S; Xia, D; Samols, D (2006) Expression of rabbit C-reactive protein in transgenic mice inhibits development of antigen-induced arthritis. Scand J Rheumatol 35:351-5
Black, Steven; Agrawal, Alok; Samols, David (2003) The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct. Mol Immunol 39:1045-54
Xia, D; Samols, D (1997) Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci U S A 94:2575-80
Zhang, D; Sun, M; Samols, D et al. (1996) STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem 271:9503-9
Zhang, D; Xia, D; Samols, D (1995) Generation of deletion mutants by partial digestion. Biotechniques 18:750-2
Lin, C S; Xia, D; Yun, J S et al. (1995) Expression of rabbit C-reactive protein in transgenic mice. Immunol Cell Biol 73:521-31
Renia, L; Rodrigues, M M; Nussenzweig, V (1994) Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology 82:164-8
Renia, L; Xia, D; Samols, D et al. (1993) Transgenic mice expressing C-reactive protein are susceptible to infection with Plasmodium yoelii sporozoites. Infect Immun 61:348-9